Viewing Study NCT01302795


Ignite Creation Date: 2025-12-24 @ 2:11 PM
Ignite Modification Date: 2026-01-08 @ 2:07 AM
Study NCT ID: NCT01302795
Status: COMPLETED
Last Update Posted: 2016-09-27
First Post: 2011-02-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Canakinumab for Pyoderma Gangrenosum
Sponsor: University of Zurich
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module